Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-08-28
1991-05-14
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544230, 544295, C07D40114, A61K 31505
Patent
active
050156462
ABSTRACT:
"Buspirone hydrochloride can exist in two polymorphic forms and the newly discoverd lower melting form, which is thermodynamically favored at pharmaceutically relevant temperatures, offers advantage in manufacture of buspirone pharmaceutical compositions".
REFERENCES:
patent: 3717634 (1973-02-01), Wu et al.
patent: 3976776 (1976-08-01), Wu et al.
patent: 4351939 (1982-09-01), Simms
patent: 4476248 (1984-10-01), Gordon
Wu, et al., J. Med. Chem., 15, 477-479 (1972), (3/13).
Allen, et al., Arzneim. Forsch., 24 No. 6, 917-922 (1972), (3/16).
Sathananthan, et al., Current Therapeutic Research, 18/5, 701-705 (1975), (3/18).
Bristol-Myers Squibb Co.
Ford John M.
Ryan Richard P.
LandOfFree
Pharmaceutically useful polymorphic modification of buspirone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutically useful polymorphic modification of buspirone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically useful polymorphic modification of buspirone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1648537